Ankur Dhingra, Chief Financial Officer at Summit Therapeutics Inc. (SMMT), bought 36,215 shares at $0.97 ($35K) on 2022-08-16, disclosed to the SEC on 2022-08-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.97 | 11,557 | $11K | 31.9% |
| 2 | $0.97 | 24,658 | $24K | 68.1% |
| Total | $0.97 avg | 36,215 | $35K | 100% |
| Filing → |
| SMMT | BUY | 2023-12-13 | $44K | — | Filing → |
| SMMT | BUY | 2023-03-08 | $13K | — | Filing → |
| SMMT | BUY | 2023-03-08 | $412K | — | Filing → |